FBLG FibroBiologics Inc

Price (delayed)

$1.33

Market cap

$8.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.19

Enterprise value

$6.8M

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 24
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 1

Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ ...

Highlights
FBLG's quick ratio has surged by 96% since the previous quarter and by 96% year-on-year
The company's debt has shrunk by 86% YoY and by 41% QoQ
The net income has declined by 37% year-on-year but it has grown by 2.9% since the previous quarter

Key stats

What are the main financial stats of FBLG

FBLG stock price

How has the FibroBiologics stock price performed over time
Intraday
-0.75%
1 week
-6.99%
1 month
-7.64%
1 year
-87.36%
YTD
-70.44%
QTD
40.34%

Financial performance

How have FibroBiologics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.73M
Net income
-$18.14M
Gross margin
N/A
Net margin
N/A
The net income has declined by 37% year-on-year but it has grown by 2.9% since the previous quarter
FibroBiologics's operating income has decreased by 4% YoY but it has increased by 2.7% QoQ

Price vs fundamentals

How does FBLG's price correlate with its fundamentals

Growth

What is FibroBiologics's growth rate over time

Valuation

What is FibroBiologics stock price valuation
P/E
N/A
P/B
1.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
FibroBiologics's EPS has increased by 27% YoY and by 25% QoQ
The P/B is 97% lower than the last 4 quarters average of 46.9
The equity has soared by 78% QoQ

Efficiency

How efficient is FibroBiologics business performance
The ROA has shrunk by 122% YoY and by 15% QoQ
The ROIC has soared by 68% YoY but it has contracted by 3.4% from the previous quarter
FibroBiologics's ROE has increased by 30% from the previous quarter and by 12% YoY

Dividends

What is FBLG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBLG.

Financial health

How did FibroBiologics financials performed over time
The total assets is 141% greater than the total liabilities
FibroBiologics's current ratio has surged by 184% YoY and by 66% QoQ
FBLG's quick ratio has surged by 96% since the previous quarter and by 96% year-on-year
The company's debt is 68% lower than its equity
The debt to equity has dropped by 97% year-on-year and by 66% since the previous quarter
The company's debt has shrunk by 86% YoY and by 41% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.